Sandbox

AVBCC

October 29-31, 2018 | New York Athletic Club, New York, NY

Monday, October 29

5:00 pm – 8:00 pm Meet and Greet Networking Reception Honoring the Charitable Foundation for National Cancer Research Swim Across America
Co-Chairs
  • Burt Zweigenhaft, Managing Partner, Upstream Partners; Co-Founder, AVBCC
  • Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • William McGivney, Principal, McGivney Global Advisors
  • Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies
Co-Chair Segment Advisors
  • Washington Legislation and Public Policy
    Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies
    Marc Samuels, JD, MPH, Managing Partner, ADVI Health LLC
  • Cancer Centers of Excellence
    Maurie Markman, MD, CMO, Cancer Treatment Centers of America
    Robert Carlson, MD, CEO, National Comprehensive Cancer Network
  • Community-Based Cancer Care
    Debra Pratt, MD, MPH, MBA, Texas Oncology
    Christian Downs, JD, MHA, CEO, Association of Community Cancer Centers
  • Value-Based Performance and Standards
    William McGivney, Partner, McGivney Global Advisors
    Mark Fendrick, MD, University of Michigan Value-Based Insurance Design
  • Real-World Performance and Value-Based Care
    Jennifer Hinkel, Partner, McGivney Global Advisors
    Brent Clough, CEO, Trio Health
  • Practice Management
    Jeffrey Scott, MD, President and CMO, Integra Connect
    Brenton Fargnoli, MD, Product Marketing & Strategy, Flatiron Health
  • Personalized Medicine and Genomics
    Louis Jacques, MD, ADVI Health LLC
    Tom Civik, Chief Commercial Officer, Foundation Medicine
  • Oncology Supply Chain and Specialty Pharmacy
    Darin Rubin, CEO, The Dedham Group
    Kelly Ratliff, President, US BioServices Division, AmerisourceBergen
  • Patient-Centered Cancer Care
    Lillie Shockney, RN, BS, MAS, Program Director and Co-Founder, Academy of Oncology Nurse & Patient Navigators
    Brenda Nevidjon, RN, MSN, CEO, Oncology Nursing Society
  • Telemedicine and Cancer Care
    Joel Stein, CEO, AdhereTech
  • Patient Voice and Advocacy
    Robert Goldberg, PhD, VP, Center for Medicine in the Public Interest
    Amy Niles, VP, Patient Access Network Foundation

Tuesday, October 30

6:30 am – 7:30 am Mini-Roundtables
6:30 am – 7:30 am Networking Breakfast – Exhibit Hall
7:30 am Opening Remarks and Greeting
Burt Zweigenhaft, Co-Chair, AVBCC
7:30 am – 8:30 am Keynote: FDA Perspectives
Scott Gottlieb, MD, FDA Commissioner
8:30 am – 9:15 am Tomorrow’s Cancer Care: A Government Policy Perspective
  • Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies
  • Faculty: John Michael O’Brien, Advisor to the Secretary & Deputy Assistant Secretary for Health Policy, U.S. Department of Health & Human Services (HHS)
9:15 am – 10:00 am Tomorrow’s Cancer Care: An Insurance Payer’s Perspective
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Bryan Loy, MD, MBA, Medical Director, Oncology, Laboratory and Personalized Medicine, Humana
    • John Fox, MD, MHA, Senior Medical Director, Priority Health
    • Steve Peskin MD, MBA, FACP, Executive Medical Director, Population Health, Horizon BCBS
10:00 am – 10:45 am Tomorrow’s Cancer Care: The Community-Based Perspective
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Barry Brooks, MD, US Oncology
    • Christian Downs, JD, MHA, CEO, Association of Community Cancer Centers
    • Debra Pratt, MD, MPH, MBA, Texas Oncology
    • Bruce Gould, MD
10:45 am – 11:15 am Tomorrow’s Cancer Care: A Center of Excellence Perspective
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Raj Garg, MD, CEO, Cancer Treatment Centers of America
    • Al Benson III, MD, Robert H. Lurie Comprehensive Cancer Center
    • Michael P. Gutnick, Executive VP and CFO, Memorial Sloan Kettering Cancer Center
11:15 am – 12:00 pm Networking Lunch – Exhibit Hall
12:00 pm – 12:45 pm Keynote: Cancer Care into the Future
Greg Simon, President, Biden Cancer Initiative
12:45 pm – 1:30 pm Tomorrow’s Cancer Care: The Employer Perspective
  • Moderator: Jonathan Fassberg, CEO, Solebury Trout
  • Faculty:
    • Robin Leopold, MD, Managing Director, Human Resources, JPMorgan Chase & Co
    • Vice President, PNC Bank (TBA)
    • Walmart (TBA)
1:30 pm – 2:15 pm Tomorrow’s Cancer Care: A Pharma Perspective
  • Moderator: William McGivney, Managing Principal, McGivney Global Advisors, LLC
  • Faculty:
    • Mikael Dolstein, MD, President, World Research and Development, Pfizer
    • Axel Hoos, MD, SVP, Head, Oncology R&D, GlaxoSmithKline
Track 1:
CLINICAL
Track 2:
ADVOCACY
Track 3:
TECHNOLOGY
Track 4:
SUPPLY CHAIN
Track 5:
BUSINESS
Track 6:
CONTRACTING
Track 7:
SPECIALTY PHARMACY
Track 8:
EMPLOYERS
2:15 pm – 3:15 pm
BREAKOUT 1: CLINICAL
CAR-T Gene Therapy Immuno-Oncology
  • Moderator: Morrie Ruffin, CEO, Adjuvant Partners
  • Faculty:
    • Alfred Slanetz, PhD, CEO, Genius Biotechnology
    • Novartis, TBD
BREAKOUT 2: TECHNOLOGY
Artificial Intelligence in Cancer Treatment Design
  • Moderator: Annatasiah Mhaka, PhD, Sr. Advisor, Adjuvant Partners
  • Faculty: TBD
BREAKOUT 3: SUPPLY CHAIN
Oncology Supply Chain
  • Moderator: Kevin Cast, Partner, Archbow Consulting
  • Faculty:
    • Rusty Massey, VP, Provider Relations, AmerisourceBergen Specialty Group, US Bioservices
    • Patrick Schmidt, CEO, FFF Enterprises
    • Lisa Harrison, Sr. Director, Pharmacy and Clinical Services, ION Solutions
BREAKOUT 4: ADVOCACY
Tomorrow’s Cancer Care: The Patient Voice and Advocate Perspective
  • Moderator: Robert Goldberg, PhD, VP, Center for Medicine in the Public Interest
  • Faculty:
    • Dan Klein, President, Patient Access Network
    • Clorinda Walley, CEO, Chronic Disease Fund
    • Patricia Goldsmith, CEO, CancerCare
    • Linda House, BSN, MSN, President, Cancer Support Community
3:15 pm – 4:15 pm
BREAKOUT 5: SUPPLY CHAIN
CAR-T Pipeline and Market Access
  • Moderator: Morrie Ruffin, CEO, Adjuvant Partners
  • Faculty:
    • Amy DuRoss, Vineti
BREAKOUT 6: TECHNOLOGY
Big Data: “The New Oil”
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Brad Hirsch, MD, Senior Medical Director, Flatiron Health
BREAKOUT 7: CONTRACTING
Oncology Medical Home and Update on the CMMI Model
  • Moderator: Pamela Pelizzari, MPH, Healthcare Consultant, Milliman
  • Faculty:
    • Anand Shah, MD, CMO, Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services
BREAKOUT 8: BUSINESS
TOPIC: TBD
  • Moderator: TBD
  • Faculty:
    • TBD
    • Charles Stevens
4:15 pm – 5:15 pm
BREAKOUT 9: CLINICAL
Genomics and Personalized Medicine
  • Moderator: Louis Jacques, MD, ADVI
  • Faculty:
    • Stan Skrzypczak, VP, Corporate Development & Reimbursement, Guardant Health
    • Vince Miller, MD, Foundation Medicine
    • Edward Abrahams, CEO, Personalized Medicine Coalition
BREAKOUT 10: CONTRACTING
Value-Based Oncology Drug Contracting
  • Moderator: Jude Gallagher, PA, MBA, Former Director, Complex Clinical Care Strategy, Humana
  • Faculty:
    • A. Mark Fendrick, MD, Center for Value-Based Insurance Design, University of Michigan
    • James Kenney Jr., RPh, MBA, VP, Harvard Pilgrim Health; President, Academy of Managed Care Pharmacy (AMCP)
    • Brian Bourbeau, MBA, Associate Director, Business Metrics and Analysis, American Society of Clinical Oncology (ASCO)
BREAKOUT 11: TECHNOLOGY
TITLE TBD
  • Moderator: Jennifer Hinkel, Partner, McGivney Global Advisors, LLC
  • Faculty:
    • Kulig
    • Weidner
    • Jackie Mitus
BREAKOUT 12: BUSINESS
Strategies for Delivering on Pharmaceutical Value, a Focus on Quality
  • Moderator: Darin Rubin, CEO, Managing Director, The Dedham Group LLC
  • Faculty:
    • Danielle Ziernicki, BS, RPh, PharmD, National Quality Forum, Steering Committee for Cancer Project, The Dedham Group LLC
    • Ira Klein, MD, Johnson & Johnson
    • Norris Turner, PharmD, PhD, Pharmacy Quality Alliance
5:00 pm – 6:00 pm Keynote – Cancer Drug Trend Report
Moderator: Burt Zweigenhaft, Co-Chair, AVBCC
Faculty: Doug Long, VP, Industry Relations, IQViA
6:00 pm – 7:30 pm Evening Network Reception

Wednesday, October 31

7:00 am – 8:00 am Mini-Roundtables
7:00 am – 7:50 am Breakfast Presentation
Oncology Drug Pipeline Overview, Next 3 Years
  • Moderator: Burt Zweigenhaft, Co-Chair, AVBCC
  • Faculty:
    • Ray Trancredi, RPh, MBA, CSP, Divisional VP, Specialty Pharmacy Development & Brand Rx/Vaccine Purchasing, Walgreens
    • Cheryl Allen, PharmD, Diplomat Specialty Pharmacy
7:50 am – 8:00 am Opening Remarks
Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
8:00 am – 9:00 am Keynote
Rowdy Gaines, Three-Time Olympic Gold Medalist and NBC Sports Commentator
Distinguished Researchers Panel
  • Moderator: Neil Canavan, Author, The Cure Within
  • Panelists:
    • Jedd Wolchok, MD, Memorial Sloan Kettering Cancer Center
    • Luis Diaz, MD, Memorial Sloan Kettering Cancer Center
    • Axel Hoos, MD, President, Oncology, GlaxoSmithKline
9:00 am – 10:00 am Cancer Care Perspectives from Capitol Hill and in Emerging Public Policy
  • Moderator: Marc Samuels, JD, MPH, Managing Partner, ADVI Health LLC
  • Faculty:
    • Kavita Patel, Fellow, Brookings Institution
    • Liz Fowler, VP, Global Health Policy, Johnson & Johnson
10:00 am – 10:45 am From K Street to Wall Street: A Look at Cancer Policy Influence on Markets
  • Moderator: Ipsita Smolinski, CEO, Capitol Street
  • Faculty:
    • Lisa Gill, JP Morgan
    • TBD PNC Bank
10:45 am – 11:45 am Understanding Value Equations: Real-World Applications and Implications
  • Moderator: William McGivney, PhD, Partner, McGivney Global Advisors LLC
  • Faculty:
    • Richard Schilsky, MD, FACP, American Society of Clinical Oncology
    • Steven Pearson, MD, MSc, President, Institute for Clinical and Economic Review
    • Peter Bach, MD, Memorial Sloan Kettering Cancer Center
    • Eric Dozier, BS, MBA, VP, North American Oncology, Eli Lilly and Company
11:45 am – 12:30 pm Lunch Presentation Cancer Treatment Innovation: Pathways, Forums, and Clinical Tools
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Robert J. Green, MD, SVP, Clinical Oncology, Flatiron Health
    • Anand Shah, MD, MPH, CMO, Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services
    • Chuck Saunders, Integra Connect
12:30 pm – 1:15 pm PANEL DISCUSSION
Pharmacy Benefit Managers & Their Role in Cancer Care Initiatives
  • Moderator: Kevin Cast, Partner, Archbow Consulting
  • Faculty:
    • Everette Neville, SPV, Supply Chain & Specialty
    • Survy Singh, MD, Corporate VP, Medical Benefit Management
    • TBD, Optum
Track 1:
CLINICAL
Track 2:
ADVOCACY
Track 3:
TECHNOLOGY
Track 4:
SUPPLY CHAIN
Track 5:
BUSINESS
Track 6:
CONTRACTING
Track 7:
SPECIALTY PHARMACY
Track 8:
EMPLOYERS
1:15 pm – 2:00 pm
BREAKOUT 1: TECHNOLOGY
Blockchain and Use Cases in Cancer Healthcare
  • Moderator: John Bass, Hashed Health
BREAKOUT 2: SPECIALTY PHARMACY
Role of the Specialty Pharmacy in Cancer Care
  • Moderator: Mark Ellis, RPh, CEO, Vineti
  • Faculty:
    • Ray Bailey, Director of Pharmacy, Florida Cancer Specialists
    • Matt Farber, Walgreens
    • Michael Reff, PharmD, President, National Community Oncology Dispensing Associations
    • Brian Siez, PharmD, President, Accredo
BREAKOUT 3: EMPLOYERS
Employers and Business Health Coalitions
  • Moderator: Randy Vogenberg, PhD, RPh, Partner, National Institute of Collaborative Healthcare
  • Faculty:
    • David Hom, Chief Evangelist, Scio Health Analytics
BREAKOUT 4: BUSINESS
Coding & Reimbursement: CAR-T Gene Therapy
  • Moderator: Joel Brill, MD, Chief Medical Officer, Predictive Health, LLC
2:00 pm – 2:45 pm
BREAKOUT 5: SUPPLY CHAIN
Panel: Optimizing Patient Services Solutions in Cancer Care
  • Moderator: DeWayne Manning, Partner, Archbow Consulting
  • Learnings:
    • “HUB” types – What Is Really Needed and by Whom?
    • Operational Optimization of Patient and Provider Support Services
    • E-Services and the Evolution to Digitization
  • Pharma Panel Members: TBD

Archbow will initiate recruitment

BREAKOUT 6:
CLINICAL Biosimilars and Impact on Cancer Care
  • Moderator: Robert Rifkin, MD, Medical Director, Biosimilars, US Oncology Network
  • Faculty:
    • TBD, Sandoz
    • Robert Shelley, Pfizer
BREAKOUT 7: BUSINESS
Examining the Market Cost of Cancer Care
  • Moderator: TBD
  • Faculty:
    • Bruce S. Pyenson, Principal and Consulting Actuary, Milliman
    • Kathryn Fitch, Principal & Healthcare Consultant, Milliman
BREAKOUT 8: BUSINESS
Standardized Measurements and Process for Navigating Cancer Care
  • Moderator: Brenda, ONS
  • Faculty:
    • Tricia Strusowski, RN, MS
    • Danelle Johnston, MSN, RN, ONN-CG, OCN
2:45 pm – 3:30 pm
BREAKOUT 9: BUSINESS
The Impact of Drug Policy Changes on Revenue of Oncology Practices
  • Moderator: Bruce S. Pyenson, Principal and Consulting Actuary, Milliman
  • Faculty: Josh Stein, CEO, AdhereTech
BREAKOUT 10: EMPLOYERS
Employers and Managing the Economic Reality of Cancer Spending
  • Moderator: Randy Vogenberg, PhD, RPh, Partner, National Institute of Collaborative Healthcare
3:30 pm – 4:00 pm Closing Remarks

*Agenda is subject to change.